NCT00776282View on ClinicalTrials.gov

Bioequivalence Study of Loratadine Orally Disintegrating Tablets 10 mg Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

September 30, 2006

Conditions
Healthy
Interventions
DRUG

loratadine 10 mg orally disintegrating

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00776282 - Bioequivalence Study of Loratadine Orally Disintegrating Tablets 10 mg Under Fed Conditions | Biotech Hunter | Biotech Hunter